News & Events

News &

Virtual panel of Cantor and Fitzgerald will discuss market opportunities in ophthalmic indications, hosting Tarsier Pharma

19 February, 2021

Tarsier pharma is pleased to contribute to the video call “Eyeing Key Events and Programs in the Ophthalmology Space in 2021” initiated by Cantor and Fitzgerald, a global financial services firm, that would take place on Friday, 19th of February 2021. The virtual meeting would be moderated by Ms. Kristen Kluska, Biotechnology Analyst, and host representatives from four ophthalmic-oriented companies, Lineage Cell Therapeutics, Ocuphire Pharma, Outlook Therapeutics and Tarsier Pharma. Panelists will discuss market opportunities across numerous indications in the ophthalmology space and share highlights about company pipelines, previously reported datasets, and upcoming milestones and events.

Please see here a recording of the event: Eyeing Key Events and Programs in the Ophthalmology Space in 2021 – Zoom

Scroll to Top